Balance Sheet
Cash Flow Statement
Amortization of GoodwillAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsCash from RestructuringChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Legend Biotech (LEGN) Capital Expenditures: 2018-2024

Historic Capital Expenditures for Legend Biotech (LEGN) over the last 7 years, with Dec 2024 value amounting to $14.1 million.

  • Legend Biotech's Capital Expenditures fell 3.20% to $545,000 in Q1 2025 from the same period last year, while for Mar 2025 it was $1.6 million, marking a year-over-year decrease of 36.25%. This contributed to the annual value of $14.1 million for FY2024, which is 29.77% down from last year.
  • As of FY2024, Legend Biotech's Capital Expenditures stood at $14.1 million, which was down 29.77% from $20.1 million recorded in FY2023.
  • Over the past 5 years, Legend Biotech's Capital Expenditures peaked at $42.2 million during FY2021, and registered a low of $14.1 million during FY2024.
  • Its 3-year average for Capital Expenditures is $18.4 million, with a median of $20.1 million in 2023.
  • Its Capital Expenditures has fluctuated over the past 5 years, first spiked by 60.73% in 2021, then slumped by 50.41% in 2022.
  • Legend Biotech's Capital Expenditures (Yearly) stood at $26.3 million in 2020, then spiked by 60.73% to $42.2 million in 2021, then slumped by 50.41% to $20.9 million in 2022, then declined by 4.03% to $20.1 million in 2023, then dropped by 29.77% to $14.1 million in 2024.